Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
42 participants
INTERVENTIONAL
2024-08-20
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults
NCT06438887
Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults
NCT06606704
Effects of Resistance-band Training and Creatine and Whey Protein
NCT06606717
Physiological Effects of Creatine Supplementation in Active Males
NCT03003988
Creatine and Motor Skill Acquisition
NCT05201651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Evidence-based research shows that creatine supplementation improves measures of body composition and muscle performance. However, the optimal creatine supplementation protocol to achieve these benefits is unknown.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Creatine Bolus
(Serving 1: 5 grams of creatine monohydrate + 3 grams of placebo in the morning; Serving 2: 8 grams of placebo in the evening) for 21 days.
Creatine
Creatine monohydrate
Creatine Intermittent
(Serving 1: 2.5 grams of creatine monohydrate + 5.5 grams of placebo in the morning; Serving 2: 2.5 grams of creatine monohydrate + 5.5 grams of placebo in the evening) for 21 days.
Creatine
Creatine monohydrate
Placebo
(Servings 1: 8 grams of placebo in the morning; Serving 2: 8 grams of placebo in the evening) for 21 days.
Placebo
Maltodextrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creatine
Creatine monohydrate
Placebo
Maltodextrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* if you have not been performing resistance training for at least 4 weeks prior to the start of the study.
Exclusion Criteria
* have taken creatine monohydrate within 30 days prior to the start of the study
* if you have pre-existing allergies to the placebo (corn-starch maltodextrin)
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iovate Health Sciences International Inc
INDUSTRY
University of Regina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Darren Candow
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darren Candow
Role: PRINCIPAL_INVESTIGATOR
University of Regina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Regina
Regina, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
834
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.